2026 Baptist Health Neuroscience Symposium

Friday, October 16, 2026, 7:45 AM - 5:30 PM CT, Little Rock, AR


The symposium aims to provide educational opportunities for nurses, EMTs, physicians, advanced practice providers, and other supporting healthcare professionals on the prevention, diagnosis and management of neuroscience patients. This event is open to all healthcare professionals.

1. Verbalize the importance of continuing education and the commitment to ensuring that the highest quality of care is delivered to their patients and families by the end of this educational offering.
2. Report an increase in knowledge about current evidence in neuroscience care for patients and their families by the end of this educational offering.
3. List at least one evidence-based care concept that they will integrate into their current and future practice by the end of this education offering.

AMA PRA Category 1 Credits™ (7.25 hours), AAPA - American Academy of PAs Category 1 CME (7.25 hours), ACPE - Accreditation Council for Pharmacy Education (7.25 hours), ACPE - Pharmacy Technician (7.25 hours), ANCC - American Nurses Credentialing Center (7.25 hours), CCM - Certified Case Managers (7.25 hours), CDR - Commission on Dietetic Registration (7.25 hours), EMS - Emergency Medical Services (7.25 hours), Non-Physician AMA PRA Category 1 Credits™ (7.25 hours)

In support of improving patient care, University of Arkansas for Medical Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Mitigation of Relevant Financial Relationships

University of Arkansas for Medical Sciences Office of Continuing Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.